Target type: biologicalprocess
Evagination of the presynaptic membrane, resulting in the formation of a new synaptic vesicle. [GOC:curators, PMID:10099709, PMID:20448150]
Synaptic vesicle budding from the presynaptic endocytic zone membrane is a complex and highly regulated process that allows for the efficient recycling of synaptic vesicle components and the maintenance of neurotransmitter release. The process begins with the formation of a clathrin-coated pit at the membrane of the presynaptic endocytic zone, a specialized region of the presynaptic terminal where synaptic vesicles are retrieved after fusion. This pit is initiated by the recruitment of clathrin, a protein that forms a lattice-like structure around the budding vesicle. Other proteins, including adaptor proteins (AP-2), dynamin, and the GTPase Rab5, are also recruited to the pit, playing crucial roles in shaping the vesicle and driving its fission from the membrane. AP-2 complexes bind to the cytoplasmic tails of transmembrane proteins in the plasma membrane, mediating the selection of specific cargo proteins destined for the budding vesicle. Dynamin, a GTPase, forms a ring-like structure around the neck of the budding vesicle and constricts the membrane, ultimately leading to vesicle scission. The newly formed vesicle, still coated with clathrin, then undergoes a series of maturation steps, including the removal of the clathrin coat and the recruitment of other proteins, such as synaptotagmin, which are essential for its future fusion with the presynaptic membrane. This process of synaptic vesicle budding is highly dynamic and tightly regulated, ensuring the efficient recycling of synaptic vesicle components and the continuous supply of synaptic vesicles for neurotransmitter release. '
"
Protein | Definition | Taxonomy |
---|---|---|
Dynamin-2 | A dynamin-2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P50570] | Homo sapiens (human) |
Dynamin-1 | A dynamin-1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q05193] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
cetrimonium bromide | cetyltrimethylammonium bromide : The organic bromide salt that is the bromide salt of cetyltrimethylammonium; one of the components of the topical antiseptic cetrimide. | organic bromide salt; quaternary ammonium salt | detergent; surfactant |
n,n-dimethyl-1-dodecanamine | N,N-dimethyl-1-dodecanamine: increases body weight & feed efficiency in animals; RN given refers to parent cpd | ||
decylamine | decylamine: structure | alkylamine | |
myristic acid | Myristic Acid: A saturated 14-carbon fatty acid occurring in most animal and vegetable fats, particularly butterfat and coconut, palm, and nutmeg oils. It is used to synthesize flavor and as an ingredient in soaps and cosmetics. (From Dorland, 28th ed) tetradecanoate : A long-chain fatty acid anion that is the conjugate base of myristic acid; major species at pH 7.3. tetradecanoic acid : A straight-chain, fourteen-carbon, long-chain saturated fatty acid mostly found in milk fat. | long-chain fatty acid; straight-chain saturated fatty acid | algal metabolite; Daphnia magna metabolite; EC 3.1.1.1 (carboxylesterase) inhibitor; human metabolite |
dodecylamine | dodecylamine: RN given refers to parent cpd | primary aliphatic amine | |
dodecyltrimethylammonium bromide | dodecyltrimethylammonium bromide : A quarternary ammonium cation having one dodecyl and three methyl substituents around the central nitrogen. | bromide salt; quaternary ammonium salt | surfactant |
stearylamine | octadecan-1-amine : An 18-carbon primary aliphatic amine. stearylamine: RN given refers to parent cpd | primary aliphatic amine | film-forming compound |
n-tetradecylamine | N-tetradecylamine: RN given refers to parent cpd | alkylamine | |
1,12-dodecamethylenediamine | 1,12-dodecamethylenediamine: RN given refers to parent cpd dodecane-1,12-diamine : An alkane-alpha,omega-diamine that is dodecane substituted by amino groups at positions 1 and 12. | alkane-alpha,omega-diamine | |
stearyltrimethylammonium bromide | octadecyltrimethylammonium bromide: structure in first source | ||
ag-213 | tyrphostin 47: inhibits protein-tyrosine kinase activity of EGF-R both in vitro and in living cells; | ||
ag 99 | tyrphostin A46: epidermal growth factor-urogastrone receptor antagonist | ||
dynole 34-2 | dynole 34-2: a dynamin inhibitor; structure in first source | ||
n'-(3,4-dihydroxybenzylidene)-3-hydroxy-2-naphthahydrazide | catechols; hydrazide; hydrazone; naphthols | EC 3.6.5.5 (dynamin GTPase) inhibitor |